Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.

ClinicalTrials.gov ID: NCT02174731

Public ClinicalTrials.gov record NCT02174731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Open-label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients

Study identification

NCT ID
NCT02174731
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
2,133 participants

Conditions and interventions

Conditions

Interventions

  • Roxadustat Drug
  • Epoetin alfa Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2014
Primary completion
Sep 25, 2018
Completion
Sep 25, 2018
Last update posted
Dec 15, 2019

2014 – 2018

United States locations

U.S. sites
51
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
Research Site Huntsville Alabama 35805
Research Site El Centro California 92243
Research Site Fairfield California 94534
Research Site Glendale California 91205
Research Site Long Beach California 90802
Research Site Long Beach California 90807
Research Site Los Angeles California 90022
Research Site Los Angeles California 90025
Research Site Lynwood California 90262
Research Site Northridge California 91324
Research Site Ontario California 91762
Research Site Orange California 92868
Research Site Riverside California 92503
Research Site Sacramento California 95825
Research Site Sun Valley California 91352
Research Site Whittier California 90602
Research Site Whittier California 90606
Research Site Denver Colorado 80230
Research Site New Haven Connecticut 06510
Research Site Miami Gardens Florida 33169
Research Site River Forest Illinois 60305
Research Site Wichita Kansas 67214
Research Site Baton Rouge Louisiana 70808
Research Site Lanham Maryland 20706
Research Site Plymouth Massachusetts 02360
Research Site Roseville Michigan 48066
Research Site Gulfport Mississippi 39501
Research Site Kansas City Missouri 64111
Research Site Reno Nevada 89511
Research Site Paterson New Jersey 07504
Research Site Great Neck New York 11021
Research Site Orchard Park New York 14127
Research Site The Bronx New York 10461
Research Site Asheville North Carolina 28805
Research Site Charlotte North Carolina 28207
Research Site Wilmington North Carolina 28401
Research Site Cincinnati Ohio 45206
Research Site Shawnee Oklahoma 74804
Research Site Bethlehem Pennsylvania 18017
Research Site Philadelphia Pennsylvania 19106
Research Site East Providence Rhode Island 02914
Research Site Austin Texas 78756
Research Site Austin Texas 78758
Research Site Houston Texas 77004
Research Site Houston Texas 77091
Research Site San Antonio Texas 78212
Research Site San Antonio Texas 78222
Research Site San Antonio Texas 78229
Research Site Newport News Virginia 23605
Research Site Sterling Virginia 20164
Research Site Bluefield West Virginia 24701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 137 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02174731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02174731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →